The spel of chronic disease patients —— Xiong Fulin
熊富林产品的应用:
Application of Xiong Fulin products:
我早在2015年就接触了作者的理论和调理产品,那时是在广州买了作者的产品。我本人在广西南宁工作,内科副主任医师。今年(2022年)5月份,因我父亲的老部下患肺癌、前列腺肥大、浅表性胃炎,让我这个从医40多年的内科医师束手无策,想起了作者。6月份以来通过作者的产品调理,患者奇迹般地各个病症得到了改善。后又从作者这里要了许多调理产品,对以前我的病患进行调理,理解了作者的慢性病理论:所有慢性病都是胰岛素抵抗不平衡引起的,而不是胰岛素抵抗引起的。
I came into contact with the author's theory and conditioning products as early as 2015, when I bought the author's products in Guangzhou. I myself work in Nanning, Guangxi, deputy chief physician of internal medicine. In May this year (2022), my father's old subordinates suffered from lung cancer, prostate hypertrophy and superficial gastritis, which, a physician who has been practicing for more than 40 years, was helpless and reminded of the author. Since June, through the author's product conditioning, the patient has miraculously improved their various diseases. Later, I asked for a lot of conditioning products from the author to recuperate my previous patients and understand the author's chronic disease theory: all chronic diseases are caused by insulin resistance imbalance, rather than insulin resistance.
通成康食疗是慢性病患者的褔气。我给许多慢性病患者用通成康调理,收到意想不到的效果。例如患者韦美连、女、56岁,因反复上腹脹痛1年余,于2022年7月21日住玉林第二人民医院,三天后出院。出院诊断:脑梗死;高血压三级、高危组;高尿酸血症;慢性浅表性胃炎伴糜烂。2022年8月1日因收缩压升至180毫米汞柱到南宁官塘一家诊所静脉输液,其费用180余元,医生叮嘱她次日再来静脉输液。
Tongchengkang diet therapy is the health of patients with chronic diseases. I gave many patients with chronic diseases with Tongchengkang conditioning, received unexpected results. For example, the patient Wei Meilian, female, 56-year-old, was admitted to Yulin Second People's Hospital on July 21,2022 due to recurrent upper abdominal distension for more than one year, and was discharged three days later. Discharge diagnosis: cerebral infarction; hypertension level 3, high-risk group; hyperuricemia; chronic superficial gastritis with erosion. On August 1,2022, due to the systolic blood pressure rising to 180 mmHg, she went to a clinic in Guantang, Nanning for intravenous infusion. The cost was more than 180 yuan. The doctor told her to return to the intravenous infusion the next day.
2022年8月2日其找我看病,我摸她的脉,每分钟仅搏起40多次,且舌体肥大舌中线向右偏,问诊中了解到她尿酸高,头痛全身不适等。我给她380毫升作者研发的产品,并告之用后不用去诊所静脉输液,该口服液安全有效,如遇不适速联系我。果不其然,次日血压正常,心率正常。渐渐的能到人民公园散步,能做一些力所能及的家务。9月9回玉林老家过中秋节,乡亲们見她,说换了一个人。2022年9月13日复诊,她无不感激地说"好多了” 她的两个儿子都来見我,并告诉我"老妈的体重增加了3、4斤,左侧的头没那么痛了,表示十分感谢。作者研发的产品在调理慢性病上如此高效,实属罕見!
On August 2,2022, she asked me to see a doctor. I touched her pulse, only tried more than 40 times per minute, and the midline of the tongue turned to the right, and she had high uric acid, headache and general discomfort. I gave her 380 ml of the product developed by the author, and told her that she did not need to go to the clinic for intravenous infusion. The oral liquid is safe and effective. Contact me in case of discomfort. Sure enough, the blood pressure was normal the next day, and the heart rate was normal. Gradually can go to the people's park for a walk, can do some housework within their power. On September 9, she returned to her hometown in Yulin for the Mid-Autumn Festival. The villagers saw her and said that she had changed herself. On September 13,2022, she said gratefully, "much better." Her two sons came to see me and told me that " my mother had gained 3 or 4 jin and her left head was not so painful, thanking her very much. It is rare for the author to be so efficient in regulating chronic diseases!
第二个病例,我本人,王和林,女,72岁,2021年12月I0号体捡发现右肺下叶后基底段有结节,大小约4㎜X3mm边界清楚。右肺上叶后段見一实性结节影,大小约4mmx3mm。我从2022年6月初开始用作者研发的通成康调理,2022年9月1日体检报告:两肺纹理规整,各肺叶内未見异常密度影。气管、支气管通畅,肺门纵隔未見肿大淋巴结。双侧胸膜无增厚,胸腔内未見积液。这对我来说,是佳音,如释重负。
In the second case, I myself, Wang Helin, female, 72 years old, in December 2021, found nodules in the posterior basal segment of the lower lobe of the right lung, with a clear boundary of about 4 ㎜ X3mm. The posterior segment of the upper lobe of the right lung was about 4mmx3mm. From the beginning of June 2022, I began to use the tong Chengkang conditioning developed by the author. On September 1,2022, the physical examination report: the texture of the two lungs was regular, and no abnormal density was seen in each lung lobe. The trachea and bronchus were patent, and no enlarged lymph nodes were observed in the hilar mediastinum. There was no bilateral pleural thickening and no effusion in the thorax. This is to me, good news, great relief.
第三个病例,何开贵,男,73岁,因高血压,收缩压高至170毫米汞柱,常年服降压药。7月初开始用通成康,停所有药物,现在收缩压稳定在130毫米汞柱左右,舒张压70几毫米汞柱。且进食量增加,味口极好,由每歺以前吃一碗米饭增到两碗米饭,精力体力增强。他女儿笑着对我说“照这样下去,老爸活100岁没问题了”。
The third case, He Jiagui, male, 73-year-old, took antihypertensive drugs due to high blood pressure and systolic blood pressure of 170 mm Hg. In early July, we started using tongchengkang and stopped all the drugs. Now the systolic blood pressure is stable at around 130 millimeters of mercury, and the diastolic blood pressure is around 70 millimeters of mercury. And the amount of food increases, the taste is excellent, from every before eating a bowl of rice to two bowls of rice, energy and physical strength enhancement. His daughter smiled and said to me, "Like this, dad can live for 100 years."
第四个病例,患者梁家体,男,55岁,2022年5月28日因“右上腹胀痛19天,院外检查肝占位15天”住广西医科大学附属肿瘤医院。2022年6月7日出院,出院诊断:1、肝恶性肿瘤/肝右叶巨块型肝癌并门脉右支癌栓形成;2、肝硬化;3、甲状腺功能亢进症。住院期间未手术,未放化疗。其6月2日检查:肝右叶見一巨块肿物信号影,大小14.8cmX9.1cmX16.3cm。门脉右支可見充盈缺损。2022年7月9日找到我求助。当时患者很虚弱,讲话的声音我都听不见。用作者的通成康给其食疗,其间患者腹部出大量紫紅色斑疹,手足起大量水疱,疹及水疱十余日逐渐消退,随之而来,患者慢慢可以干家务,还能开三轮车。2022年8月15日检查:肝右叶可見一实肿块,大小约12.0cmX8.0cmX15.5cm,较2022年6月2日检查明显缩小。現在患者还在用通成康食疗,能下地协助割稻谷。其预后在覌察中。4个月的调理,堪称奇迹。
In the fourth case, patient Liang Jiatai, male, 55 years old, was admitted to the Affiliated Cancer Hospital of Guangxi Medical University on May 28,2022 due to "right upper abdominal distension for 19 days and out-of-hospital liver examination for 15 days". On June 7,2022, he was discharged for diagnosis: 1. Liver malignant tumor / giant mass of the right lobe of liver cancer with the right branch of the portal vein; 2. cirrhosis; 3. hyperthyroidism. There was no surgery and no chemoradiotherapy during hospitalization. Its June 2 examination: the right lobe of the liver saw a huge mass of mass signal shadow, size 14.8cmX9.1cmX16.3cm. A filling defect was seen in the right branch of the portal artery. Find me for help on July 9,2022. The patient was so weak that I couldn't hear the voice of the speech. With the author's Tong Chengkang to its diet, during which the patient abdomen out of a large number of purple rash, a large number of hands and feet, rash and blisters more than ten days gradually subsided, followed, the patient can slowly do housework, but also can drive a tricycle. Examination on August 15,2022: a solid mass was visible in the right lobe of the liver, about 12.0cmX8.0cmX15.5cm in size, which was significantly smaller compared with the examination on June 2,2022. Now the patient is still using tongchengkang diet therapy, which can help to cut rice. Its prognosis is under observation. Four months of conditioning, it is a miracle.
我用作者的产品正在调理着许多病人,以后逐一如实报告。作者把慢性病的病因通过实践总结出来,又回到实践中去。通过本人,联系中医机构与作者合作,用作者的调理产品取得了非常好的效果。有了作者的理论实践,慢性病的救治会取得突破性的进展,天下慢性病能得到救治,获得健康乃至长寿。我认为,对于一些久治不癒的慢性病患者,不妨另辟路径,服用一下作者研发的优异产品通成康,或许能给你带来莫大的惊喜!
I use the author's product to regulate many patients, later one by one truthfully report. The author summed up the causes of chronic diseases through practice and went back to practice. Through myself, contact the traditional Chinese medicine institutions and cooperate with the author, with the author's conditioning products have achieved very good results. With the author's theory and practice, the treatment of chronic diseases will make a breakthrough, and the world of chronic diseases can be treated, obtain health and even longevity. In my opinion, for some chronic disease patients who have not been cured for a long time, you might as well take another way and take the excellent product developed by the author, which may bring you a great surprise!
这本书写出了与现代医学不一样的理论,是本人从医40多年前所末有的。读来兴奋不已。
This book writes a different theory from modern medicine, which I was a doctor more than 40 years ago. Read it was very excited.
《慢性病中的糖尿病》序
Preface to diabetes in Chronic Diseases
北海人民医院(三甲医院)主任医师 周西连
Beihai People's Hospital (three class a hospital) chief physician Zhou Xilian
这本书的观点与主流医学的观点是相反的,但分析过程是有依据和符合科学逻辑的,也不难看懂,实质上就是科普书。只不过这个科普用在世界医学难题、糖尿病的病因的探索上,是一本值得所有慢性病,特别是糖尿病医生和患者认真看阅的书。
The view of this book is contrary to the view of mainstream medicine, but the analysis process is based on and in line with the scientific logic, and it is not difficult to understand, it is essentially a popular science book. However, this popular science is used in the world's medical problems and the exploration of the cause of diabetes. It is a book worth reading for all chronic diseases, especially diabetic doctors and patients.
几年前就认识作者,是一个北海的企业领导介绍的。这个领导服用作者的产品,效果非常好。作者对于慢性病的病因,有自己完整的、独立的、系统化的理论体系。糖尿病并发症,特别是慢性并发症的病因不在于高血糖,不在于胰岛素抵抗,而在于胰岛素抵抗的不平衡。
I met the author a few years ago and was introduced by a Beihai business leader. This leader took the author's product, and the results were very good. The author has his own complete, independent and systematic theoretical system for the etiology of chronic diseases. The etiology of diabetic complications, especially chronic complications, is not hyperglycemia, insulin resistance, but the imbalance of insulin resistance.
第一、高血糖与慢性并发症之间是伴生关系,不是因果关系。细胞葡萄糖吸收流量符合肌体的要求(作者定义为胰岛素抵抗平衡),就不会出现慢性并发症,但细胞葡萄糖吸收流量过小或过大时(作者定义为胰岛素抵抗不平衡),就会出现慢性并发症或肥胖。作者纠正了现代医学对胰岛素抵抗概念的不精确性,提出了胰岛素抵抗平衡与不平衡的概念。
第一、First, the relationship between hyperglycemia and chronic complications is associated, not a causal relationship. Cellular glucose uptake flow meets the requirements of the body (the authors define as insulin resistance balance), but chronic complications or obesity occur when the cellular glucose uptake flow is too small or too large (the authors define as unbalanced insulin resistance). The author corrects the imprecision of the concept of insulin resistance in modern medicine and proposes the concept of balance and imbalance of insulin resistance.
2、最重要的是作者提出了代谢与胰岛素抵抗的关系。代谢的动力是胰岛素抵抗要平衡。胰岛素抵抗平衡后代谢才会稳定,才会不发生紊乱。代谢发生紊乱的目的是平衡胰岛素抵抗。胰岛素抵抗平衡是代谢的最高宗旨,代谢变动的目的是时刻围绕胰岛素抵抗平衡。血糖升高是阻止胰岛素抵抗不平衡的代谢调节,而不是慢性并发症的原因。慢性并发症是长期的胰岛素抵抗不平衡引起的结果。所以,高血糖与慢性并发症都是由胰岛素抵抗不平衡引起,两者的原因相同,是伴生关系。
2、Most importantly, the authors propose a relationship between metabolism and insulin resistance. The power of metabolism is insulin resistance. Insulin resistance after the metabolism will be stable, will not occur disorder. The is is to balance insulin resistance. Insulin resistance balance is the highest tenet of metabolism, and the purpose of metabolic changes is to balance around insulin resistance. Elevated blood glucose is the cause of the metabolic regulation that prevents unbalanced insulin resistance rather than chronic complications. Chronic complications are the result of a long-term imbalance of insulin resistance. Therefore, both hyperglycemia and chronic complications are caused by insulin resistance imbalance, with the same reason and the associated relationship.
临床上,我们能控制血糖,但控制不了慢性病,其原因是血糖高即糖尿病并不是慢性并发症原因。糖尿病不可怕,可怕是并发症;我们能打赢降血糖的战斗,但会输掉整个救治糖尿病的战争。这两句话是大家认可的结论,主流医学并没有去认真分析。高血糖与慢性并发症有关系不是没有关系,只是两者是伴生关系,而不是因果关系。2型糖尿病开始于胰岛素代偿过多分泌,血糖稳定,其目的是增加胰岛素含量,平衡胰岛素抵抗。当胰岛素分泌受限后,增加胰岛素含量去平衡胰岛素抵抗就无能为力,只能增加血糖去平衡胰岛素抵抗。所以降血糖不利于胰岛素抵抗的平衡。降血糖是胰岛素的附带作用,胰岛素的真正作用是促进细胞吸收葡萄糖,葡萄糖被吸收后,血糖就会下降。阻止细胞葡萄糖吸收流量减少,除了降血糖外,还必须保持一定的血糖值,否则会出现低血糖症。
Clinically, we can control blood sugar, but cannot control chronic diseases. The reason is that high blood sugar, or diabetes, is not the cause of chronic complications. Diabetes is not terrible, terrible is a complication; we can win the battle, but lose the whole battle for diabetes. These two sentences are the accepted conclusion, the mainstream medicine did not seriously analyze. It is not unrelated, but it is a related relationship, not a causal relationship. Type 2 diabetes begins with excessive secretion of insulin compensation and stable blood sugar, which is designed to increase insulin content and balance insulin resistance. When insulin secretion is limited, there is nothing done to increase insulin content to balance insulin resistance, and it can only increase blood glucose to balance insulin resistance. So lowering glucose is not conducive to the balance of insulin resistance. Lower blood glucose is a collateral effect of insulin. The real effect of insulin is to promote cells to absorb glucose, and when glucose is absorbed, blood sugar will drop. Prevent cell glucose absorption flow reduction, in addition to lowering blood glucose, must also maintain a certain blood glucose value, otherwise hypoglycemia will occur.
我们应对糖尿病,降血糖有一个多世纪,但到今天为止,糖尿病还是不治之症,其原因就是没有搞清楚高血糖与慢性并发症的关系。目前出来的新药都是犯老错误,去着眼于降血糖。
We have dealt with diabetes and lowered blood sugar for more than a century, but today, diabetes is still incurable, because we don't understand the relationship between hyperglycemia and chronic complications. New drugs are making old mistakes to focus on lowering blood sugar.
第二、胰岛素含量并不是由胰岛β细胞的功能来决定,而是由刺激和限制胰岛β细胞分泌胰岛素的条件来决定。什么时候开始分泌胰岛素,分泌多少?什么时候减少胰岛素分泌,减少多少?都不是胰岛β细胞说了算,都是刺激和限制胰岛β细胞的条件决定了胰岛素的分泌。这一点主流医学没有搞清楚。不搞清楚这一点,糖尿病的救治就非常不靠谱。
第二、insulin content is not determined by the function of islet β cells, but by the conditions that stimulate and restrict insulin secretion by islet β cells. When do you start producing insulin, and how much? When to reduce insulin secretion, and how much? Neither is islet β cells, it is the conditions that stimulate and restrict islet β cells that determine insulin secretion. This is not clear in mainstream medicine. Without understanding this, the treatment of diabetes is very unreliable.
第三、肥胖与2型糖尿病都是胰岛素抵抗不平衡引起的,肥胖并不是2型糖尿病的原因,2型糖尿病也不是肥胖的原因。人体的胰岛素抵抗不平衡开始是在局部发生,并不是在全身发生。如胰岛素抵抗不平衡在眼底首先发生,则代谢调节在加大眼底胰岛素抵抗中抵的力量的同时,也会加大除眼底以外的胰岛素抵抗中抵的力量,使除眼底以外的胰岛素抵抗中抵的力量加大,并增加除眼底以外的肌体细胞葡萄糖吸收流量并产生肥胖。胰岛素抵抗中抗的力量是局部的,胰岛素抵抗中抵的力量是全局的。局部的抗的力量增加会让全局的胰岛素抵抗中抵的力量加大,并造成没有增加抗的力量的肌体细胞葡萄糖吸收流量增加,并形成肥胖。要消除肥胖,就要平衡胰岛素抵抗的不平衡,让局部的胰岛素抵抗不平衡变成平衡。
第三、Obesity and type 2 diabetes are both caused by insulin resistance imbalance. Obesity is not the cause of type 2 diabetes, and type 2 diabetes is not the cause of obesity. The imbalance in insulin resistance in humans begins to occur locally, not throughout the body. Such as insulin resistance imbalance in the fundus first, the metabolic regulation in the strength at the same time, also can increase the strength of insulin resistance outside the fundus, make except outside the fundus of the insulin resistance of the strength, and increase besides the fundus body cells glucose absorption flow and produce obesity. The force of insulin resistance is local, and the force of insulin resistance is global. The increased force of local resistance will increase the strength of the global insulin resistance, and cause increased glucose absorption flow of body cells without increased resistance, and form obesity. To eliminate obesity, it is necessary to balance the imbalance of insulin resistance and make the local insulin resistance imbalance into balance
第四、1型糖尿病的病因是出在肝脏上,而不是出在胰岛β细胞上。理解了本序的第二点,就会理解胰岛素分泌不足的原因。
第四、The etiology of type 1 diabetes is on the liver, not on the pancreatic islet β cells. Understanding the second point of this order, you will understand the cause for insufficient insulin secretion.
在理论上,作者提出了全新的理解,看后让人觉得忐忑不安:难道现在主流医学在理解慢性病中的糖尿病时都是错了?在实践上,作者还有调理2型糖尿病的食疗产品,这才是作者提出与现代主流医学观点不一样的支撑力。在作者产品调理过程中,完全能对得上本书的理论,因此,该书理论得到实践的印证。
In theory, the author proposes a new understanding, which makes people feel uneasy: Is mainstream medicine now wrong in understanding diabetes in chronic diseases? In practice, the author also has therapeutic products to regulate type 2 diabetes, which is the author is different from the modern mainstream medical views. In the process of the author's product conditioning, he can fully understand the theory of the book, so the theory of the book has been confirmed by practice.
希望能重视此书的观点,造福慢性病患者。
I hope that the views of this book will be valued to benefit patients with chronic diseases.
